Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
David Cameron will stand down as Conservative leader ahead of the general election expected in 2020, Iain Duncan Smith said.
Delegates at the SNP spring conference have backed a move to allow all-female shortlists in the Scottish Parliament election next year.
Michael Clarke ended his one-day international career by leading Australia to a simple World Cup final win over New Zealand.